Precigen Inc. Aktie
Finanztrends
Deine Einschätzung
Precigen Inc. Aktie
Abwärts geht es heute für die Precigen Inc. Aktie mit einem Verlust von -2,09 %.
Was spricht für und gegen Precigen Inc. in den nächsten Jahren?
Pro
?
U****************
?
M************
?
L*********** I********** f** d** n******* J****
Kontra
?
W******* i* V********
?
A****************
?
M****
Sag uns deine Meinung, um die 'Wisdom of the Crowds' zu nutzen
Rendite von Precigen Inc. im Vergleich
| Wertpapier | Ver.(%) | 1W | 1M | 1J | YTD | 3J | 5J |
|---|---|---|---|---|---|---|---|
| Precigen Inc. | -2,09 % | 7,24 % | -7,06 % | 252,94 % | 27,69 % | 319,47 % | 3,49 % |
| Mighty River Power Ltd | 0,00 % | 0,00 % | 2,48 % | 5,10 % | 5,77 % | -7,82 % | -14,51 % |
| A2A SpA | -1,45 % | 1,30 % | 2,99 % | 6,54 % | 2,09 % | 36,69 % | 32,56 % |
| CEMIG ADR | -1,06 % | -0,54 % | 0,00 % | 19,35 % | 8,19 % | -21,61 % | 25,26 % |
Kommentare
News
What Does the Sale of Precigen Shares Worth $1.1 Million by the CFO Mean for Investors?
On July 1, 2026, Precigen (NASDAQ:PGEN) Chief Financial Officer Harry Thomasian Jr. reported the sale of 200,000 shares of common stock in multiple open-market transactions between June 29 and July
Is Precigen (PGEN) a Stock to Sell After Its CFO Let Go of 41,000 Shares?
Harry Thomasian Jr. Chief Financial Officer of Precigen (NASDAQ:PGEN), reported the sale of 41,884 shares of common stock on May 28, 2026, as disclosed in the SEC Form 4 filing.
Transaction value
Precigen Q1 Earnings Call Highlights
Precigen (NASDAQ:PGEN) reported a sharp increase in first-quarter 2026 revenue as the company’s first commercial product, PAPZIMEOS, continued its U.S. launch following FDA approval in August 2025
